Navigation Links
Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Date:11/9/2007

ear 1 and maintained at Year 5.

The safety analysis represents five years of cumulative data. This includes all patients who received at least one dose of ORENCIA during the one-year double-blind period and all patients who entered the open-label period who received at least one dose of ORENCIA plus all patients randomized to receive placebo (n=287). The incidence rates observed during the five-year cumulative period for serious adverse events (SAEs), infections, serious infections, malignancies and autoimmune events were consistent with both the double-blind period and the integrated safety summary, which is comprised of seven core RA studies representing approximately 8,400 patient years of exposure. The incidence rates for SAEs in the double-blind period, five-year cumulative period and the integrated safety summary were 20/100 pt-years, 18.9/100 pt-yrs and 15.4/100 pt-yrs, respectively. The incidence rates for infections in the double-blind period, five-year cumulative period and the integrated safety summary were 94.2/100 pt-years, 77.3/100 pt-yrs and 79.2/100 pt-yrs, respectively. The incidence rates for serious infections in the double-blind period, five-year cumulative period and the integrated safety summary were 2.1/100 pt-years, 3.0/100 pt-yrs and 3.0/100 pt-yrs, respectively. The incidence rates for malignancies in the double-blind period, five-year cumulative period and the integrated safety summary were 2.1/100 pt- years, 1.5/100 pt-yrs and 1.3/100 pt-yrs, respectively. A total of 12 autoimmune disorders, the most frequent of which were psoriasis and cutaneous vasculitis, were reported in 12 patients in the cumulative study period.

During the five-year cumulative period, 32 patients (11.1 percent) discontinued due to SAEs. A total of five deaths occurred through five years of the study; all were considered to be unlikely related or unrelated to study medication.

About ORENCIA(R) (abatacept)

ORENCIA is indicated in the United Sta
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
5. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
6. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
7. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
8. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
9. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
11. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015  Acsis Inc., the market leader for supply ... that John DiPalo , Acsis, Chief Strategy Officer, ... Chain Executive 2015 Provider Pro to Know. The ... to help prepare their companies, and customers, supply chains ... year,s list of Provider Pros to Know is featured ...
(Date:2/27/2015)... WASHINGTON , Feb. 27, 2015  Following ... Means Committee that moved H.R. 284, the Medicare ... the American Association for Homecare (AAHomecare) released a ... quick action to pass the legislation. ... in the House Ways and Means Committee is ...
(Date:2/27/2015)... 2015 - ... di monitoraggio dell,infarto congestizio (CHF - Congestive Heart ...     Vectorious Medical Technologies, ... per il monitoraggio cardiaco destinato a pazienti affetti ... aver concluso una raccolta di finanziamenti per 5 ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... II Trial Results,For Novel Oral Thrombin Receptor ... American College Of Cardiology/i2 Summit, KENILWORTH, N.J., ... today that results of the,Phase II trial ... (TRA),SCH 530348 will be presented at the ...
... SAN CARLOS, Calif., March 19, 2007 /PRNewswire-FirstCall/ --,Nuvelo, ... ANTHEM,(Anticoagulation with rNAPc2 To Help Eliminate MACE)/TIMI 32 ... c2,(rNAPc2) in patients with non-ST-elevation acute coronary syndromes,(NSTE-ACS) ... the of,Cardiology (ACC) 56th Annual Scientific Session taking ...
Cached Medicine Technology:Media Advisory: ACC Updated Schedule 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 2Nuvelo Announces Presentation on rNAPc2 at American College of,Cardiology 56th Annual Scientific Session 3
(Date:2/27/2015)... Miami Beach, Florida (PRWEB) February 27, 2015 ... largest non-profit organization devoted exclusively to funding innovative lymphoma ... series of education programs, outreach initiatives and patient services ... the South Florida community, returning to the greater Miami ... the La Gorce Country Club in Miami Beach on ...
(Date:2/27/2015)... 2015 "After studying the benefits and risks ... prenatal spina bifida repair may outweigh the risks for those ... range," says Fetal Care Institute Director Dr. Mike Vlastos, ... specialist. "The goal of the study is to gain ... and their unborn babies." , Studies have shown that mothers ...
(Date:2/27/2015)... February 27, 2015 Over 440,000 patients die ... the equivalent of two jumbo jet airplanes crashing each day. ... band together in an effort to do all they can ... Dr. Richard Carmona, the 17th U.S. Surgeon General, discusses the ... to be able to address safety issues to ensure that ...
(Date:2/27/2015)... Jupiter Medical Center and The Mount Sinai ... New York at Jupiter Medical Center, to enhance cardiac ... , “This innovative collaboration with Mount Sinai Heart New ... care in our very own backyard,” said John D. ... Center. “This kind of innovative thinking will transform cardiac ...
(Date:2/27/2015)... 2015 Muscular Dystrophy Association research ... at Duke University, recently announced a potentially game-changing ... men with Duchenne muscular dystrophy (DMD). The results ... Gersbach will discuss their implications at MDA's 2015 ... Washington, D.C. , Background: Gersbach and team ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Returns to Miami Beach For Exclusive Swirl Wine Tasting Event 2Health News:Pregnant Women with a BMI above 35 Now Eligible for Fetal Spina Bifida Repair Surgery Study at the St. Louis Fetal Care Institute 2Health News:Pregnant Women with a BMI above 35 Now Eligible for Fetal Spina Bifida Repair Surgery Study at the St. Louis Fetal Care Institute 3Health News:Dr. Richard Carmona, the 17th U.S. Surgeon General, and IntelliCentrics Raise Awareness in Mediaplanet’s “Patient Safety” Campaign 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 4Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 5Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2
... Younger at American Society of ... Plastic Surgeons Annual Meeting, BALTIMORE, Oct. 28 ... to looking younger. In fact,plastic surgeons analyze facial features and configurations ... in, say,presenters today at the American Society of Plastic Surgeons (ASPS) ...
... diagnosis is vital; symptoms can often mimic digestive problems , , ... had a reputation as a silent killer, because many people ... But women suffering from the disease knew differently. They knew ... patient. , "Survivors for years have said there are symptoms ...
... a condition called gastroschisis varies greatly by hospital, according to ... have a hole in their abdomen near the umbilical cord. ... the only abdominal anomaly, is fairly easy to repair, and ... suggest that in some hospitals, far fewer babies who should ...
... men born with a severe urological anomaly in which ... more robust sexual lives than women born with the ... urologists at the Johns Hopkins Childrens Center. The condition, ... surgeries throughout infancy and childhood and into early adolescence.The ...
... Four More Years of Borrowing for Iraq War,and Denying ... Howard Dean,Chairman of the Democratic National Committee, delivered the ... while all of the,Republican presidential candidates support borrowing $196 ... $7 billion next year for the,bipartisan plan to provide ...
... ... Meeting, BALTIMORE, Oct. 27 ... are making headlines. But are these procedures really ready to,be a part ... new discoveries or just "buyer beware" marketing,hype this week at the American ...
Cached Medicine News:Health News:Facelift, Botox, or Both? Depends Upon Your Decade of Life 2Health News:Facelift, Botox, or Both? Depends Upon Your Decade of Life 3Health News:New Guidelines Should Improve Ovarian Cancer Detection 2Health News:New Guidelines Should Improve Ovarian Cancer Detection 3Health News:Democratic Radio Address 2Health News:Democratic Radio Address 3Health News:Non-Invasive Fat-Melting Procedures - Hype or Reality? 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: